WeVote
Log In

Bill

Bill

S 3851

Relates to review of blood donations of patients with certain illnesses

2025 Regular Session Introduced by Pam Helming and 1 co-sponsor

Bill S 3851 establishes a review process for blood donations from patients with certain illnesses, ensuring safety while allowing eligible patients to donate.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 3851

Summary of Bill S 3851

Bill Overview

  • Bill Number: S 3851
  • Title: Relates to review of blood donations of patients with certain illnesses
  • Status: Referred to Health Committee
  • Introduced On: January 30, 2025
  • Classification: Legislative Bill

Purpose and Intent

Bill S 3851 aims to establish a framework for the review of blood donations from patients diagnosed with specific illnesses. The intent is to ensure the safety and integrity of the blood supply while addressing the needs of patients who may wish to donate blood despite their medical conditions.

Key Provisions

  • Review Process: The bill mandates a systematic review of blood donations from individuals with certain illnesses. This includes establishing criteria for eligibility and safety assessments.
  • Criteria for Illnesses: While the specific illnesses are not detailed in the provided information, the bill is likely to focus on conditions that may affect blood quality or pose risks to recipients.
  • Collaboration with Health Authorities: The bill emphasizes collaboration with health authorities and blood donation organizations to develop guidelines and protocols for the review process.
  • Public Awareness Campaigns: The bill may include provisions for public education regarding blood donation eligibility, particularly for individuals with specific health conditions.

Affected Parties

  • Patients with Certain Illnesses: Individuals diagnosed with specific conditions who wish to donate blood will be directly impacted by the new review process.
  • Blood Donation Organizations: Organizations involved in blood collection and distribution will need to adapt their protocols in accordance with the new guidelines established by the bill.
  • Healthcare Providers: Medical professionals will play a role in assessing patient eligibility and educating patients about their options regarding blood donation.

Legislative Timeline

  • January 30, 2025: Bill introduced and referred to the Health Committee.
  • June 9, 2025: The bill was discharged from committee and committed to rules, followed by an order for third reading.
  • June 10, 2025: The bill passed the Senate and was delivered to the Assembly, where it was again referred to the Health Committee for further consideration.

Related Legislation

Bill S 3851 is related to several prior-session bills, including:
- S 7208
- S 1303
- S 2217
- S 5060
- A 7955 (companion bill)

These related bills may provide additional context or frameworks that inform the provisions of S 3851.

Conclusion

Bill S 3851 represents a significant step towards enhancing the safety of the blood donation process for individuals with certain illnesses. By establishing a clear review process and promoting collaboration among health authorities, the bill aims to balance the needs of patients with the imperative of maintaining a safe blood supply. As it moves through the legislative process, further details will likely emerge regarding the specific illnesses covered and the operational implications for blood donation organizations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.